Literature DB >> 21419501

Toll-like receptor signaling in neural plasticity and disease.

Eitan Okun1, Kathleen J Griffioen, Mark P Mattson.   

Abstract

Toll-like receptors (TLRs) are a family of innate immune system receptors that respond to pathogen-derived and tissue damage-related ligands. TLR signaling in immune cells, glia and neurons can play roles in the pathogenesis of stroke, Alzheimer's disease (AD) and multiple sclerosis (MS). Recent findings suggest that TLR signaling also influences multiple dynamic processes in the developing and adult central nervous system including neurogenesis, axonal growth and structural plasticity. In addition, TLRs are implicated in the regulation of behaviors including learning, memory and anxiety. This review describes recently discovered and unexpected roles for TLRs in neuroplasticity, and the implications of these findings for future basic and translational research studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419501      PMCID: PMC3095763          DOI: 10.1016/j.tins.2011.02.005

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  105 in total

Review 1.  Regulating B-cell activation and survival in response to TLR signals.

Authors:  Steve Gerondakis; Raelene J Grumont; Ashish Banerjee
Journal:  Immunol Cell Biol       Date:  2007-07-17       Impact factor: 5.126

2.  Toll-like receptors modulate adult hippocampal neurogenesis.

Authors:  Asya Rolls; Ravid Shechter; Anat London; Yaniv Ziv; Ayal Ronen; Rinat Levy; Michal Schwartz
Journal:  Nat Cell Biol       Date:  2007-08-19       Impact factor: 28.824

Review 3.  Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis.

Authors:  Frank C Gibson; Takashi Ukai; Caroline A Genco
Journal:  Front Biosci       Date:  2008-01-01

4.  Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

Authors:  Silke Walter; Maryse Letiembre; Yang Liu; Holger Heine; Botond Penke; Wenlin Hao; Barbara Bode; Nicole Manietta; Jessica Walter; Walter Schulz-Schuffer; Klaus Fassbender
Journal:  Cell Physiol Biochem       Date:  2007

5.  Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia.

Authors:  Seija Lehnardt; Sabrina Lehmann; David Kaul; Katharina Tschimmel; Olaf Hoffmann; Sabine Cho; Christina Krueger; Robert Nitsch; Andreas Meisel; Joerg R Weber
Journal:  J Neuroimmunol       Date:  2007-09-12       Impact factor: 3.478

Review 6.  Toll-like receptor (TLR)-based networks regulate neutrophilic inflammation in respiratory disease.

Authors:  I Sabroe; M K B Whyte
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

7.  Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals.

Authors:  Jill S Cameron; Lena Alexopoulou; Jacob A Sloane; Allitia B DiBernardo; Yinghua Ma; Bela Kosaras; Richard Flavell; Stephen M Strittmatter; Joseph Volpe; Richard Sidman; Timothy Vartanian
Journal:  J Neurosci       Date:  2007-11-21       Impact factor: 6.167

8.  Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion.

Authors:  Fang Hua; Jing Ma; Tuanzhu Ha; Yeling Xia; Jim Kelley; David L Williams; Race L Kao; I William Browder; John B Schweitzer; John H Kalbfleisch; Chuanfu Li
Journal:  J Neuroimmunol       Date:  2007-09-19       Impact factor: 3.478

Review 9.  Regulatory T cells and toll-like receptors: regulating the regulators.

Authors:  Roger Sutmuller; Anja Garritsen; Gosse J Adema
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

10.  TLR3 deficiency in patients with herpes simplex encephalitis.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Sophie Ugolini; Asma Smahi; Gaëlle Elain; Pedro Romero; David Segal; Vanessa Sancho-Shimizu; Lazaro Lorenzo; Anne Puel; Capucine Picard; Ariane Chapgier; Sabine Plancoulaine; Matthias Titeux; Céline Cognet; Horst von Bernuth; Cheng-Lung Ku; Armanda Casrouge; Xin-Xin Zhang; Luis Barreiro; Joshua Leonard; Claire Hamilton; Pierre Lebon; Bénédicte Héron; Louis Vallée; Lluis Quintana-Murci; Alain Hovnanian; Flore Rozenberg; Eric Vivier; Frédéric Geissmann; Marc Tardieu; Laurent Abel; Jean-Laurent Casanova
Journal:  Science       Date:  2007-09-14       Impact factor: 47.728

View more
  197 in total

Review 1.  The immunology of neurodegeneration.

Authors:  Eva Czirr; Tony Wyss-Coray
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  Xtalk: a path-based approach for identifying crosstalk between signaling pathways.

Authors:  Allison N Tegge; Nicholas Sharp; T M Murali
Journal:  Bioinformatics       Date:  2015-09-23       Impact factor: 6.937

3.  Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.

Authors:  Changyoun Kim; Edward Rockenstein; Brian Spencer; Hyung-Koo Kim; Anthony Adame; Margarita Trejo; Klodjan Stafa; He-Jin Lee; Seung-Jae Lee; Eliezer Masliah
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

4.  Young and aged TLR4 deficient mice show sex-dependent enhancements in spatial memory and alterations in interleukin-1 related genes.

Authors:  Opal V Potter; Megan E Giedraitis; Charles D Johnson; Mackenzie N Cox; Rachel A Kohman
Journal:  Brain Behav Immun       Date:  2018-10-27       Impact factor: 7.217

Review 5.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

6.  Treatment with Histone Deacetylase Inhibitor Attenuates Peripheral Inflammation-Induced Cognitive Dysfunction and Microglial Activation: The Effect of SAHA as a Peripheral HDAC Inhibitor.

Authors:  Naoki Takada; Yoki Nakamura; Keisuke Ikeda; Naoki Takaoka; Kazue Hisaoka-Nakashima; Seigo Sanoh; Yaichiro Kotake; Yoshihiro Nakata; Norimitsu Morioka
Journal:  Neurochem Res       Date:  2021-06-03       Impact factor: 3.996

7.  Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.

Authors:  Florence R Theberge; Xuan Li; Sarita Kambhampati; Charles L Pickens; Robyn St Laurent; Jennifer M Bossert; Michael H Baumann; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

8.  Toll-like receptor 4 enhancement of non-NMDA synaptic currents increases dentate excitability after brain injury.

Authors:  Ying Li; Akshata A Korgaonkar; Bogumila Swietek; Jianfeng Wang; Fatima S Elgammal; Stella Elkabes; Vijayalakshmi Santhakumar
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

9.  (+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors.

Authors:  Eva M Medina-Rodriguez; Kenner C Rice; Eléonore Beurel; Richard S Jope
Journal:  Brain Behav Immun       Date:  2020-08-26       Impact factor: 7.217

10.  CD36-mediated hematoma absorption following intracerebral hemorrhage: negative regulation by TLR4 signaling.

Authors:  Huang Fang; Jing Chen; Sen Lin; PengFei Wang; YanChun Wang; XiaoYi Xiong; QingWu Yang
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.